🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Hindustan Zinc stock faces valuation headwinds, says Citi while raising price target

EditorEmilio Ghigini
Published 21/10/2024, 10:08
HZNC
-

On Monday, Citi updated its stance on Hindustan Zinc (HZ:IN) stock, raising the stock's price target to INR400.00 from INR325.00, while continuing to recommend a Sell.

The firm's analysis highlighted Hindustan Zinc's second-quarter EBITDA, which saw a year-over-year increase of approximately 31% due to higher zinc and silver prices, increased volumes, and reduced costs. The cost of production (CoP) excluding royalty decreased to $1,071 from $1,107 in the previous quarter.

The company's EBITDA margin improved to 50% compared to 49% in the first quarter and 46% in the same period last year. Management has confirmed their forecast for growth in refined metal production between 4-6% for the fiscal year 2025, with silver production expected to increase by 1-4% and CoP targeted at $1,050-1,100 per tonne.

Despite the price target increase, Citi reiterated its Sell rating on the stock, citing valuation concerns. According to Citi's estimates, Hindustan Zinc is trading at 11 times its expected FY26 enterprise value to EBITDA (EV/EBITDA), which is higher than the company's historical average of 8.5 times over three years and 7.5 times over five years. These projections assume zinc prices at $3,050 per tonne, with the current spot price at $3,000.

Citi's revised price target incorporates their updated forecasts for zinc, lead, and silver prices for the fiscal year 2026, which are now set at $3,050, $2,100, and $32.5 per ounce, respectively, compared to the previous estimates of $2,800 for zinc, $2,200 for lead, and $31 for silver.

The report also notes the sensitivity of Hindustan Zinc's EBITDA and fair value to fluctuations in commodity prices, stating that every $100 per tonne change in zinc-lead prices impacts EBITDA by 4% and fair value by INR17 per share. Similarly, a $1 per ounce change in silver prices affects EBITDA by 1% and fair value by INR4 per share.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.